UNSPSC 51373321: Aspirin/propoxyphene

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN101. This VA Drug Class (CN101) classifies this compound as belonging to the group OPIOID ANALGESICS.

UNSPSC 51373321 Aspirin/propoxyphene is a Commodity code that does not align with the recent state and local procurement activity tagged under it. The only recent opportunity in the dataset is Seminole County, Florida's IFB 60459723LAS for naloxone and drug deactivation systems — opioid antagonists and harm-reduction equipment wholly outside the scope of aspirin and propoxyphene analgesics. The mismatch suggests either a classification error in the county's tagging or a system that has repurposed this code for other pharmaceutical products. State and local procurement under this code cannot be meaningfully characterized from available data.

Seminole County issued the sole recent opportunity as an IFB with a response deadline of July 26, 2023, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The contract carries a two-year initial term with one-year renewal option, fixed-fee pricing structure, and standard compliance requirements including drug-free workplace certification, E-Verify eligibility confirmation, and insurance coverage (workers' compensation, commercial general liability, and professional liability). Potential FEMA funding introduces Clean Air Act and Federal Water Pollution Control Act compliance obligations. Given the absence of representative activity aligned with the code's nominal scope, this code does not present a viable procurement pathway for aspirin or propoxyphene suppliers.